دورية أكاديمية
أعرض في EDS

Exogenous Ochronosis.

التفاصيل البيبلوغرافية
العنوان: Exogenous Ochronosis.
المؤلفون: Bhattar PA; Department of Dermatology, Dr. D. Y. Patil Hospital and Research Institute, Nerul, Navi Mumbai, India., Zawar VP; Skin Diseases Centre, Nashik, Maharashtra, India., Godse KV; Department of Dermatology, Dr. D. Y. Patil Hospital and Research Institute, Nerul, Navi Mumbai, India., Patil SP; Department of Dermatology, Dr. D. Y. Patil Hospital and Research Institute, Nerul, Navi Mumbai, India., Nadkarni NJ; Department of Dermatology, Dr. D. Y. Patil Hospital and Research Institute, Nerul, Navi Mumbai, India., Gautam MM; Department of Dermatology, Dr. D. Y. Patil Hospital and Research Institute, Nerul, Navi Mumbai, India.
المصدر: Indian journal of dermatology [Indian J Dermatol] 2015 Nov-Dec; Vol. 60 (6), pp. 537-43.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 0370750 Publication Model: Print Cited Medium: Internet ISSN: 1998-3611 (Electronic) Linking ISSN: 00195154 NLM ISO Abbreviation: Indian J Dermatol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: Mumbai : Medknow Publications
Original Publication: Calcutta : Indian Association of Dermatologists, Venerologists and Leprologists, West Bengal Branch.
مستخلص: Exogenous ochronosis (EO) is a cutaneous disorder characterized by blue-black pigmentation resulting as a complication of long-term application of skin-lightening creams containing hydroquinone but may also occur due to topical contact with phenol or resorcinol in dark-skinned individuals. It can also occur following the use of systemic antimalarials such as quinine. EO is clinically and histologically similar to its endogenous counterpart viz., alkaptonuria, which, however, exhibits systemic effects and is an inherited disorder. Dermoscopy and in vivo skin reflectance confocal microscopy are noninvasive in vivo diagnostic tools. It is very difficult to treat EO, a cosmetically disfiguring and troubling disorder with disappointing treatment options.
References: J Am Acad Dermatol. 2000 May;42(5 Pt 2):869-71. (PMID: 10767690)
Cutis. 1988 Jul;42(1):19-20. (PMID: 3203531)
N Engl J Med. 1977 Dec 29;297(26):1471-2. (PMID: 927473)
Indian J Dermatol. 2011 Mar;56(2):194-6. (PMID: 21716546)
An Bras Dermatol. 2012 Jul-Aug;87(4):633-6. (PMID: 22892783)
S Afr Med J. 1979 Nov 3;56(19):757-60. (PMID: 505210)
Br J Dermatol. 1989 Feb;120(2):229-38. (PMID: 2923796)
Arch Dermatol. 1985 Oct;121(10):1239-40. (PMID: 4037813)
J Am Acad Dermatol. 2007 Nov;57(5):854-72. (PMID: 17467115)
Indian J Dermatol Venereol Leprol. 2013 Jul-Aug;79(4):522-3. (PMID: 23760323)
J Am Acad Dermatol. 1993 Apr;28(4):662-4. (PMID: 8463477)
Indian J Dermatol. 2009 Jul;54(3):299-301. (PMID: 20161872)
Arch Dermatol Res. 1979 Aug;266(1):1-9. (PMID: 159671)
J Cosmet Dermatol. 2004 Dec;3(4):234-6. (PMID: 17166112)
J Am Acad Dermatol. 1986 Aug;15(2 Pt 2):357-61. (PMID: 3734183)
J Am Acad Dermatol. 1983 Jun;8(6):882-9. (PMID: 6863651)
Indian J Dermatol. 2012 Sep;57(5):394-5. (PMID: 23112363)
J Eur Acad Dermatol Venereol. 2011 Jul;25(7):842-50. (PMID: 21108660)
J Cosmet Dermatol. 2010 Dec;9(4):313-7. (PMID: 21122051)
S Afr Med J. 1980 Feb 9;57(6):187-90. (PMID: 7361208)
S Afr Med J. 1975 Aug 9;49(34):1391-5. (PMID: 1162515)
J Bone Joint Surg Br. 1970 Nov;52(4):653-66. (PMID: 5487565)
Int J Dermatol. 2008 Jan;47(1):19-23. (PMID: 18173595)
J Am Acad Dermatol. 1990 Mar;22(3):529-31. (PMID: 2312837)
J Am Acad Dermatol. 1984 Jun;10(6):1072-3. (PMID: 6736332)
J Cosmet Laser Ther. 2013 Oct;15(5):274-8. (PMID: 23464825)
Int J Dermatol. 2010 Jan;49(1):101; author reply 101. (PMID: 20465625)
Clin Med Res. 2004 Nov;2(4):209-15. (PMID: 15931360)
An Bras Dermatol. 2011 Jul-Aug;86(4 Suppl 1):S31-4. (PMID: 22068765)
Crit Rev Toxicol. 1999 May;29(3):283-330. (PMID: 10379810)
Am J Clin Dermatol. 2001;2(4):213-7. (PMID: 11705248)
BMJ. 1992 Oct 17;305(6859):903-4. (PMID: 1458069)
J Dermatol Surg Oncol. 1990 Nov;16(11):1018-22. (PMID: 2246407)
Dermatol Ther. 2007 Sep-Oct;20(5):314-21. (PMID: 18045356)
Am J Dermatopathol. 1986 Feb;8(1):14-21. (PMID: 3706666)
S Afr Med J. 1990 Apr 7;77(7):373. (PMID: 2321111)
Arch Dermatol. 2010 Sep;146(9):1021-5. (PMID: 20855704)
J Am Acad Dermatol. 1983 Jan;8(1):123. (PMID: 6826796)
J Am Acad Dermatol. 1988 Nov;19(5 Pt 2):942-6. (PMID: 3192777)
Am J Dermatopathol. 1991 Aug;13(4):418-24. (PMID: 1928626)
Dermatol Surg. 2004 Apr;30(4 Pt 1):555-8. (PMID: 15056151)
Br J Dermatol. 1975 Dec;93(6):613-22. (PMID: 1220808)
Int J Toxicol. 2010 Nov-Dec;29(6 Suppl):274S-87. (PMID: 21164074)
فهرسة مساهمة: Keywords: Exogenous ochronosis; hydroquinone; melasma
تواريخ الأحداث: Date Created: 20151218 Date Completed: 20151217 Latest Revision: 20181113
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4681189
DOI: 10.4103/0019-5154.169122
PMID: 26677264
قاعدة البيانات: MEDLINE
الوصف
تدمد:1998-3611
DOI:10.4103/0019-5154.169122